Graham Capital Management, L.P. Bio Techne Corp Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $901,332 - $1.33 Million	-17,061 Reduced 85.73%	2,840 $219,000
Q3 2023 Nov 22, 2023	BUY	$67.52 - $89.42 $1.34 Million - $1.78 Million	19,901 New	19,901 $1.35 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $728,017 - $880,492	10,165 Added 262.73%	14,034 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $312,112 - $1.36 Million	3,869 New	3,869 $320,000
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $729,879 - $1.02 Million	2,262 New	2,262 $784,000

616

156M

200K

15.3K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.